Carroll Financial Associates’s Vanguard Short-Term Treasury ETF VGSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.69M Buy
27,730
+822
+3% +$50.3K 0.09% 136
2021
Q3
$1.65M Buy
26,908
+74
+0.3% +$4.55K 0.09% 138
2021
Q2
$1.65M Sell
26,834
-261
-1% -$16.1K 0.09% 134
2021
Q1
$1.67M Buy
27,095
+1,605
+6% +$98.8K 0.1% 125
2020
Q4
$1.57M Buy
25,490
+1,280
+5% +$79.3K 0.1% 124
2020
Q3
$1.5M Buy
24,210
+1,610
+7% +$100K 0.12% 110
2020
Q2
$1.41M Buy
22,600
+3,467
+18% +$216K 0.12% 111
2020
Q1
$1.19M Buy
19,133
+5,331
+39% +$327K 0.12% 112
2019
Q4
$839K Buy
13,802
+10,934
+381% +$666K 0.07% 155
2019
Q3
$174K Buy
2,868
+328
+13% +$20K 0.02% 393
2019
Q2
$154K Buy
2,540
+1,906
+301% +$115K 0.01% 402
2019
Q1
$38K Buy
634
+223
+54% +$13.4K ﹤0.01% 616
2018
Q4
$24K Buy
+411
New +$24.6K ﹤0.01% 630

Other funds holding VGSH

Carroll Financial Associates's VGSH Position: Q4 2021 in Review

Carroll Financial Associates increased its Vanguard Short-Term Treasury ETF (VGSH) stake by 3.1% in Q4 2021, buying an estimated $50.3K and bringing the position to 27,730 shares worth $1.69M. The position accounts for 0.09% of the portfolio, ranked #136.

Carroll Financial Associates first reported a position in VGSH in Q4 2018 and has held it in 13 quarters since. 557 funds tracked by Wall St. Rank hold VGSH as of Q4 2021.

  • Carroll Financial Associates held 27,730 shares of Vanguard Short-Term Treasury ETF worth $1.69M as of Q4 2021.
  • Carroll Financial Associates bought 822 Vanguard Short-Term Treasury ETF shares in Q4 2021, an estimated $50.3K.
  • Vanguard Short-Term Treasury ETF made up 0.09% of Carroll Financial Associates's portfolio in Q4 2021, its #136 holding.
  • Carroll Financial Associates first reported a position in Vanguard Short-Term Treasury ETF in Q4 2018 and has held it in 13 quarters since.
  • 557 funds tracked by Wall St. Rank held Vanguard Short-Term Treasury ETF as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.